PortfoliosLab logoPortfoliosLab logo
IBRX vs. GME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IBRX vs. GME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ImmunityBio, Inc. (IBRX) and GameStop Corp. (GME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBRX achieves a 264.65% return, which is significantly higher than GME's 5.28% return. Over the past 10 years, IBRX has underperformed GME with an annualized return of 1.77%, while GME has yielded a comparatively higher 15.49% annualized return.


IBRX

1D
-1.90%
1M
0.00%
YTD
264.65%
6M
218.06%
1Y
151.57%
3Y*
38.97%
5Y*
-12.44%
10Y*
1.77%

GME

1D
-1.77%
1M
-3.73%
YTD
5.28%
6M
-2.76%
1Y
-9.89%
3Y*
-3.74%
5Y*
-17.36%
10Y*
15.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBRX vs. GME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBRX
ImmunityBio, Inc.
264.65%-22.66%-49.00%-0.99%-16.61%-54.39%251.72%226.72%-74.16%-21.50%
GME
GameStop Corp.
5.28%-35.93%78.78%-5.04%-50.24%687.63%209.87%-50.19%-22.17%-23.66%

Correlation

The correlation between IBRX and GME is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.30

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jul 28, 2015

0.23

Fundamentals

EPS

IBRX:

-$0.89

GME:

$1.81

PS Ratio

IBRX:

49.31

GME:

3.08

Total Revenue (TTM)

IBRX:

$140.98M

GME:

$2.90B

Gross Profit (TTM)

IBRX:

$132.23M

GME:

$943.30M

EBITDA (TTM)

IBRX:

-$196.14M

GME:

$418.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBRX vs. GME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRX
IBRX Risk / Return Rank: 8383
Overall Rank
IBRX Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
IBRX Sortino Ratio Rank: 8585
Sortino Ratio Rank
IBRX Omega Ratio Rank: 8282
Omega Ratio Rank
IBRX Calmar Ratio Rank: 8787
Calmar Ratio Rank
IBRX Martin Ratio Rank: 8080
Martin Ratio Rank

GME
GME Risk / Return Rank: 2929
Overall Rank
GME Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
GME Sortino Ratio Rank: 2828
Sortino Ratio Rank
GME Omega Ratio Rank: 2828
Omega Ratio Rank
GME Calmar Ratio Rank: 3030
Calmar Ratio Rank
GME Martin Ratio Rank: 3030
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRX vs. GME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and GameStop Corp. (GME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IBRXGMEDifference
Sharpe ratioReturn per unit of total volatility

+1.74

Sortino ratioReturn per unit of downside risk

+2.78

Omega ratioGain probability vs. loss probability

1.31

0.98

+0.33

Calmar ratioReturn relative to maximum drawdown

3.60

-0.35

+3.96

Martin ratioReturn relative to average drawdown

6.15

-0.64

+6.79

IBRX vs. GME - Sharpe Ratio Comparison

The current IBRX Sharpe Ratio is 1.46, which is higher than the GME Sharpe Ratio of -0.28. The chart below compares the historical Sharpe Ratios of IBRX and GME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IBRX vs. GME - Drawdown Comparison

The maximum IBRX drawdown since its inception was -97.30%, roughly equal to the maximum GME drawdown of -93.43%. Use the drawdown chart below to compare losses from any high point for IBRX and GME.


Loading charts...

Drawdown Indicators


IBRXGMEDifference

Max Drawdown

Largest peak-to-trough decline

-97.30%

-93.43%

-3.87%

Max Drawdown (1Y)

Largest decline over 1 year

-42.34%

-27.99%

-14.35%

Max Drawdown (3Y)

Largest decline over 3 years

-79.34%

-62.42%

-16.92%

Max Drawdown (5Y)

Largest decline over 5 years

-91.75%

-83.83%

-7.92%

Max Drawdown (10Y)

Largest decline over 10 years

-97.03%

-88.99%

-8.04%

Current Drawdown

Current decline from peak

-82.91%

-75.67%

-7.24%

Average Drawdown

Average peak-to-trough decline

-84.38%

-49.30%

-35.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.76%

15.59%

+9.17%

Volatility

IBRX vs. GME - Volatility Comparison

ImmunityBio, Inc. (IBRX) has a higher volatility of 18.35% compared to GameStop Corp. (GME) at 8.49%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than GME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBRXGMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.35%

8.49%

+9.86%

Volatility (6M)

Calculated over the trailing 6-month period

88.53%

27.92%

+60.61%

Volatility (1Y)

Calculated over the trailing 1-year period

104.49%

36.11%

+68.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

113.44%

94.89%

+18.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.42%

117.92%

-6.50%

Dividends

IBRX vs. GME - Dividend Comparison

Neither IBRX nor GME has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GME
GameStop Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%6.25%12.04%8.47%5.86%5.14%
IBRX
ImmunityBio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

IBRX vs. GME - Financials Comparison

This section allows you to compare key financial metrics between ImmunityBio, Inc. and GameStop Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
44.21M
0
(IBRX) Total Revenue
(GME) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IBRX and GME have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBRX has higher volatility (18.35%) compared to GME (8.49%). In terms of maximum drawdown, IBRX dropped -97.30% vs GME's -93.43%.

IBRX currently has the higher Sharpe Ratio (1.46 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBRX and GME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer